[
  {
    "ts": null,
    "headline": "Hellman & Friedman Explores Potential Cordis Sale at Up to $10 Billion",
    "summary": "The private equity firm is sounding out interest in the cardiovascular device maker, with talks early and no decision yet to sell.",
    "url": "https://finnhub.io/api/news?id=959a84b51294129dff8bf04847266d58f3355c787224967adf3579af32ad7ba6",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768829339,
      "headline": "Hellman & Friedman Explores Potential Cordis Sale at Up to $10 Billion",
      "id": 138176996,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CAH",
      "source": "Yahoo",
      "summary": "The private equity firm is sounding out interest in the cardiovascular device maker, with talks early and no decision yet to sell.",
      "url": "https://finnhub.io/api/news?id=959a84b51294129dff8bf04847266d58f3355c787224967adf3579af32ad7ba6"
    }
  },
  {
    "ts": null,
    "headline": "Will Robust Adult Nutrition Business Performance Fuel ABT's Q4 Earnings?",
    "summary": "ABT heads into Q4 earnings with adult nutrition in focus, as Ensure and Glucerna launches are expected to support modest segment growth.",
    "url": "https://finnhub.io/api/news?id=5726d83a89e11a2239f4363b3292e078d30064fe3db96baf1e87ec28b0df089d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768826220,
      "headline": "Will Robust Adult Nutrition Business Performance Fuel ABT's Q4 Earnings?",
      "id": 138177993,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CAH",
      "source": "Yahoo",
      "summary": "ABT heads into Q4 earnings with adult nutrition in focus, as Ensure and Glucerna launches are expected to support modest segment growth.",
      "url": "https://finnhub.io/api/news?id=5726d83a89e11a2239f4363b3292e078d30064fe3db96baf1e87ec28b0df089d"
    }
  }
]